• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺癌中等分割立体定向体部放射治疗期间肿瘤体积的变化

Variation of Tumor Volume During Moderate Hypo-Fractionated Stereotactic Body Radiation Therapy for Lung Cancer.

作者信息

Nishimura Keiichiro, Hatanaka Shogo, Utsumi Nobuko, Yamano Takafumi, Shimbo Munefumi, Takahashi Takeo

机构信息

Department of Radiation Oncology, Saitama Medical Center, Saitama Medical University, Kawagoe, JPN.

Department of Radiation Therapy, JCHO Tokyo Shinjuku Medical Center, Tokyo, JPN.

出版信息

Cureus. 2021 Sep 5;13(9):e17743. doi: 10.7759/cureus.17743. eCollection 2021 Sep.

DOI:10.7759/cureus.17743
PMID:34659956
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8491798/
Abstract

Aim To investigate the variation of tumor volume during moderate hypo-fractionated stereotactic body radiation therapy (SBRT). Patients and Methods Twenty patients, who received SBRT at our institution, were included in the analysis. A prescribed dose was 56 Gy at iso-center in seven fractions. Tumor volumes before and during SBRT were calculated. In order to investigate factors affecting the variation of tumor volume in RT 2 (after first irradiation) and RT 7 (after last irradiation), various parameters were verified by the Mann-Whitney test. Results With regard to the low maximum standardized uptake values (SUVmax) group, transient increase of tumor volume was found in RT 2, and tumor volume reduction was hardly found in RT 7. With regard to the high SUVmax group, a transient increase was not found, and a definite reduction was found in the treatment course. Conclusion Accurate prediction of tumor volume variation is required for more accurate treatment, such as adaptive radiation therapy.

摘要

目的 探讨中等分割立体定向体部放射治疗(SBRT)期间肿瘤体积的变化。患者与方法 分析在本机构接受SBRT的20例患者。等中心处方剂量为56 Gy,分7次照射。计算SBRT前及治疗期间的肿瘤体积。为研究影响放疗第2次(首次照射后)和第7次(末次照射后)肿瘤体积变化的因素,采用Mann-Whitney检验验证各项参数。结果 低最大标准化摄取值(SUVmax)组在放疗第2次时肿瘤体积出现短暂增大,在放疗第7次时几乎未发现肿瘤体积缩小。高SUVmax组未出现短暂增大,在治疗过程中发现肿瘤体积有明确缩小。结论 为实现更精确的治疗,如自适应放射治疗,则需要准确预测肿瘤体积变化。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b951/8491798/8e4ac90b173e/cureus-0013-00000017743-i06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b951/8491798/81a345b2d715/cureus-0013-00000017743-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b951/8491798/07a7012e7421/cureus-0013-00000017743-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b951/8491798/5213b4976d4b/cureus-0013-00000017743-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b951/8491798/07480c6d65e4/cureus-0013-00000017743-i04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b951/8491798/484f2a08746f/cureus-0013-00000017743-i05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b951/8491798/8e4ac90b173e/cureus-0013-00000017743-i06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b951/8491798/81a345b2d715/cureus-0013-00000017743-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b951/8491798/07a7012e7421/cureus-0013-00000017743-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b951/8491798/5213b4976d4b/cureus-0013-00000017743-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b951/8491798/07480c6d65e4/cureus-0013-00000017743-i04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b951/8491798/484f2a08746f/cureus-0013-00000017743-i05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b951/8491798/8e4ac90b173e/cureus-0013-00000017743-i06.jpg

相似文献

1
Variation of Tumor Volume During Moderate Hypo-Fractionated Stereotactic Body Radiation Therapy for Lung Cancer.肺癌中等分割立体定向体部放射治疗期间肿瘤体积的变化
Cureus. 2021 Sep 5;13(9):e17743. doi: 10.7759/cureus.17743. eCollection 2021 Sep.
2
Re-irradiation stereotactic body radiotherapy for spinal metastases: a multi-institutional outcome analysis.脊柱转移瘤的再程立体定向体部放射治疗:多机构疗效分析
J Neurosurg Spine. 2016 Nov;25(5):646-653. doi: 10.3171/2016.4.SPINE151523. Epub 2016 Jun 24.
3
Formula corrected maximal standardized uptake value in FDG-PET for partial volume effect and motion artifact is not a prognostic factor in stage I non-small cell lung cancer treated with stereotactic body radiotherapy.针对部分容积效应和运动伪影校正后的18F-氟脱氧葡萄糖正电子发射断层扫描中的最大标准化摄取值,并非立体定向体部放疗治疗的I期非小细胞肺癌的预后因素。
Ann Nucl Med. 2015 Oct;29(8):666-73. doi: 10.1007/s12149-015-0991-5. Epub 2015 Jun 4.
4
Postoperative re-irradiation using stereotactic body radiotherapy for metastatic epidural spinal cord compression.使用立体定向体部放射治疗对转移性硬膜外脊髓压迫症进行术后再照射。
J Neurosurg Spine. 2018 Sep;29(3):332-338. doi: 10.3171/2018.1.SPINE171155. Epub 2018 Jun 15.
5
Lymphocyte-sparing effect of stereotactic body radiation therapy compared to conventional fractionated radiation therapy in patients with locally advanced pancreatic cancer.立体定向体部放射治疗与常规分割放射治疗局部晚期胰腺癌患者的淋巴细胞保护作用比较。
BMC Cancer. 2019 Oct 22;19(1):977. doi: 10.1186/s12885-019-6220-1.
6
Radiation-Induced Dyspnea in Lung Cancer Patients Treated with Stereotactic Body Radiation Therapy.立体定向体部放射治疗的肺癌患者中放射性呼吸困难
Cancers (Basel). 2021 Jul 25;13(15):3734. doi: 10.3390/cancers13153734.
7
Assessment of Monte Carlo algorithm for compliance with RTOG 0915 dosimetric criteria in peripheral lung cancer patients treated with stereotactic body radiotherapy.评估蒙特卡罗算法在接受立体定向体部放射治疗的周围型肺癌患者中符合 RTOG 0915 剂量学标准的应用。
J Appl Clin Med Phys. 2016 May 8;17(3):277-293. doi: 10.1120/jacmp.v17i3.6077.
8
Pretreatment maximum standardized uptake value on 18F-fluorodeoxyglucose positron emission tomography is a predictor of outcome for stage I non-small cell lung cancer after stereotactic body radiotherapy.18F-氟脱氧葡萄糖正电子发射断层扫描的预处理最大标准化摄取值是立体定向体部放疗后I期非小细胞肺癌预后的一个预测指标。
Asia Pac J Clin Oncol. 2016 Mar;12(1):e113-7. doi: 10.1111/ajco.12128. Epub 2013 Oct 31.
9
Vertebral compression fractures after stereotactic body radiation therapy: a large, multi-institutional, multinational evaluation.立体定向体部放射治疗后椎体压缩骨折:一项大型、多机构、跨国评估。
J Neurosurg Spine. 2016 Jun;24(6):928-36. doi: 10.3171/2015.10.SPINE141261. Epub 2016 Feb 19.
10
Phase 2 Study of Stereotactic Body Radiation Therapy and Stereotactic Body Proton Therapy for High-Risk, Medically Inoperable, Early-Stage Non-Small Cell Lung Cancer.立体定向体部放疗和立体定向体部质子治疗高危、不可手术、早期非小细胞肺癌的 2 期研究。
Int J Radiat Oncol Biol Phys. 2018 Jul 1;101(3):558-563. doi: 10.1016/j.ijrobp.2018.02.022. Epub 2018 Mar 2.

本文引用的文献

1
Phase I study of stereotactic body radiation therapy for centrally located stage IA non-small cell lung cancer (JROSG10-1).立体定向体部放射治疗中央型IA期非小细胞肺癌的I期研究(JROSG10-1)
Int J Clin Oncol. 2017 Oct;22(5):849-856. doi: 10.1007/s10147-017-1125-y. Epub 2017 May 2.
2
Elderly patients undergoing SBRT for inoperable early-stage NSCLC achieve similar outcomes to younger patients.接受立体定向体部放疗(SBRT)的老年不可手术早期非小细胞肺癌(NSCLC)患者与年轻患者的治疗效果相似。
Lung Cancer. 2016 Jul;97:22-7. doi: 10.1016/j.lungcan.2016.04.011. Epub 2016 Apr 19.
3
Radiobiology of hypofractionated stereotactic radiotherapy: what are the optimal fractionation schedules?
大分割立体定向放射治疗的放射生物学:最佳分割方案是什么?
J Radiat Res. 2016 Aug;57 Suppl 1(Suppl 1):i76-i82. doi: 10.1093/jrr/rrw015. Epub 2016 Mar 22.
4
Prospective Trial of Stereotactic Body Radiation Therapy for Both Operable and Inoperable T1N0M0 Non-Small Cell Lung Cancer: Japan Clinical Oncology Group Study JCOG0403.立体定向体部放疗治疗可手术和不可手术 T1N0M0 期非小细胞肺癌的前瞻性研究:日本临床肿瘤学组研究 JCOG0403。
Int J Radiat Oncol Biol Phys. 2015 Dec 1;93(5):989-96. doi: 10.1016/j.ijrobp.2015.07.2278. Epub 2015 Nov 11.
5
Fatal complications after stereotactic body radiation therapy for central lung tumors abutting the proximal bronchial tree.立体定向体部放射治疗毗邻近端支气管树的中央型肺肿瘤后的致命并发症。
Pract Radiat Oncol. 2016 Mar-Apr;6(2):e27-33. doi: 10.1016/j.prro.2015.09.012. Epub 2015 Nov 11.
6
Stereotactic ablative radiotherapy (SABR) for central lung tumors: Plan quality and long-term clinical outcomes.中央型肺肿瘤的立体定向消融放疗(SABR):计划质量与长期临床疗效
Radiother Oncol. 2015 Oct;117(1):64-70. doi: 10.1016/j.radonc.2015.09.028.
7
Tumour volume changes assessed with high-quality KVCT in lung cancer patients undergoing concurrent chemoradiotherapy.在接受同步放化疗的肺癌患者中,用高质量千伏级计算机断层扫描(KVCT)评估肿瘤体积变化。
Br J Radiol. 2015 Aug;88(1052):20150156. doi: 10.1259/bjr.20150156. Epub 2015 Jun 9.
8
Toxicity after central versus peripheral lung stereotactic body radiation therapy: a propensity score matched-pair analysis.中央型与周围型肺癌立体定向体部放射治疗后的毒性反应:一项倾向评分匹配对分析。
Int J Radiat Oncol Biol Phys. 2015 Jan 1;91(1):124-32. doi: 10.1016/j.ijrobp.2014.08.345. Epub 2014 Oct 18.
9
Gross tumour volume variations in primary non-small-cell lung cancer during the course of treatment with stereotactic body radiation therapy.原发性非小细胞肺癌在立体定向体部放射治疗过程中的肿瘤总体积变化
J Med Imaging Radiat Oncol. 2014;58(3):384-91. doi: 10.1111/1754-9485.12168. Epub 2014 Mar 5.
10
Tumor volume change with stereotactic body radiotherapy (SBRT) for early-stage lung cancer: evaluating the potential for adaptive SBRT.立体定向体部放疗(SBRT)治疗早期肺癌的肿瘤体积变化:评估适应性 SBRT 的潜力。
Am J Clin Oncol. 2015 Feb;38(1):41-6. doi: 10.1097/COC.0b013e318287bd7f.